Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients

Last updated: July 6, 2010
Sponsor: Hospital Authority, Hong Kong
Overall Status: Trial Status Unknown

Phase

N/A

Condition

Pulmonary Arterial Hypertension

Mucositis

Treatment

N/A

Clinical Study ID

NCT00563498
EC1432-00
HARECCTR0500034
  • Ages > 18
  • All Genders

Study Summary

The primary purpose of this project is to investigate if addition of glutamine, an amino acid, to standard parenteral nutrition, may improve the clinical outcome of the bone marrrow transplantation reducing the occurrence of veno-occlusive disease and severity of mucositis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Allogeneic bone marrow transplant recipients using busulfan and cyclophosphamide as conditioning.

Study Design

Total Participants: 40
Study Start date:
July 01, 2004
Estimated Completion Date:
June 30, 2006

Connect with a study center

  • Queen Mary Hospital

    Hong Kong,
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.